Lobbying activity

Q3

KING & SPALDING LLP for BECKER & POLIAKOFF P.A., ON BEHALF OF THE CITY OF MIAMI

3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · $20,000.00 income

Budget/Appropriations

View → Q3

KING & SPALDING LLP for IEM INTERNATIONAL INC.

3rd Quarter (July 1 - Sep 30) 2025 · North Carolina · House · Senate · $20,000.00 income

Disaster Planning/Emergencies

View → Q3

KING & SPALDING LLP for PRYSMIAN CABLES AND SYSTEMS USA, LLC

3rd Quarter (July 1 - Sep 30) 2025 · Kentucky · $20,000.00 income

Manufacturing, Energy/Nuclear

View → Q3

KING & SPALDING LLP for MUELLER WATER PRODUCTS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · Georgia · $10,000.00 income

Manufacturing, Trade (domestic/foreign)

View → Q3

KING & SPALDING LLP for RAGAN & MASSEY, LLC.

3rd Quarter (July 1 - Sep 30) 2025 · Louisiana · House · Senate · $30,000.00 income

Trade (domestic/foreign), Budget/Appropriations

View → Q3Y

KING & SPALDING LLP for QUALITY DIALYSIS CENTER LAS TUNAS LLC

3rd Quarter (July 1 - Sep 30) 2025 · California

View → 3TY

KING & SPALDING LLP for PRELUDEDX

3rd Quarter (July 1 - Sep 30) 2025 · California

View → Q3

KING & SPALDING LLP for LIFEGIFT

3rd Quarter (July 1 - Sep 30) 2025 · Texas · House · Senate · $40,000.00 income

Health Issues

View → Q3

KING & SPALDING LLP for AMERICAN COLLEGE OF MEDICAL GENETICS

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $20,000.00 income

Health Issues

View → Q3

KING & SPALDING LLP for POINTCLICKCARE TECHNOLOGIES, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · $50,000.00 income

Health Issues

View → Q3

KING & SPALDING LLP for AFLAC INCORPORATED

3rd Quarter (July 1 - Sep 30) 2025 · Georgia · House · Senate · $60,000.00 income

Insurance

View → Q3

KING & SPALDING LLP for VOICES OF ALZHEIMER'S, INC.

3rd Quarter (July 1 - Sep 30) 2025 · North Carolina · House · Senate · $70,000.00 income

Government Issues

View → Q3

KING & SPALDING LLP for ST. PETERSBURG COLLEGE FOUNDATION, INC.

3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · Senate · $30,000.00 income

Education

View → Q3

KING & SPALDING LLP for SENIOR CARE PHARMACY COALITION

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 income

Medicare/Medicaid

View → Q3

KING & SPALDING LLP for SEABOARD CORPORATION

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · $20,000.00 income

Agriculture, Transportation

View → Q3

KING & SPALDING LLP for RAI SERVICES COMPANY (FORMERLY KNOWN AS RJ REYNOLDS)

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $10,000.00 income

Tobacco

View → Q3

KING & SPALDING LLP for PHOTOCURE, INC.

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $70,000.00 income

Health Issues

View → Q3

KING & SPALDING LLP for PADRON CIGARS

3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · Senate · $60,000.00 income

Tobacco

View → 3A

KING & SPALDING LLP for MOLECULIGHT CORPORATION

3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $30,000.00 income

Medicare/Medicaid

View → Q3

KING & SPALDING LLP for MULTICARE HEALTH SYSTEM

3rd Quarter (July 1 - Sep 30) 2025 · Washington · House · Senate · $30,000.00 income

Health Issues

View → Q3

KING & SPALDING LLP for MOLECULIGHT CORPORATION

3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $30,000.00 income

Medicare/Medicaid

View → Q3

KING & SPALDING LLP for MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL)

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $140,000.00 income

Medicare/Medicaid

View → Q3

KING & SPALDING LLP for MARC COALITION

3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · $60,000.00 income

Medicare/Medicaid

View → Q3

KING & SPALDING LLP for KIDNEY TRANSPLANT COLLABORATIVE

3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $60,000.00 income

Health Issues

View → Q3

KING & SPALDING LLP for KANEKA PHARMA AMERICA, LLC

3rd Quarter (July 1 - Sep 30) 2025 · California · House · $30,000.00 income

Medicare/Medicaid

View →